NEU neuren pharmaceuticals limited

NEU Vs Reata, page-30

  1. 34,438 Posts.
    lightbulb Created with Sketch. 9327
    Nothing is identical, comparison is just a quick snapshot of illustrating the valuation gap between the two.

    Acadia involvement has pros and cons, obviously eroding some profit but taking risk off. NEU is just picking ~US$1b prepayments and milestone payments, plus 10-20s% royalties on every dollar net sales globally, that’s virtually no costs required, all these payments and royalties go straight towards profit. So you make adjustments accordingly.

    Also as you are aware 2591 could be bigger than DAYBUE.

    All imo.
    Last edited by 8horse: 17/11/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.